From this joint effort, it has born the Catalan Institute of Nanoscience and Nanotechnology (ICN2) located at the campus of the Autonomous University of Barcelona.
United States, Israel, Switzerland and Catalonia researchers will speak about the evolution of biological design principles, essential to describe new biotechnological solutions.
This spin-off, one of the runners-up for the BioEmprenedorXXI award, is developing a new therapy to treat sepsis. 25% of patients in ICUs develop this infection.